T HE PURPOSE of this paper is to evaluate the role of antibiotics in the management of bacterial endocarditis. Particular emphasis will be placed on those patients who exhibit increased bacterial resistance to penicillin and other antibiotics. The clinical response to antibiotics will be correlated with in vitro bacterial sensitivity studies.
MANAGEMENT OF BACTERIAL ENDOCARDITIS AT THE Los ANGELES CouNTY HOSPITAL
During the three year period, 1947 to 1949 inclusive, 64 patients with bacterial endocarditis were observed at the Los Angeles County Hospital. Except for a few minor variations, the management of these patients conformed to the following routine: Once a positive blood culture had been obtained, the in vitro sensitivity of the organism to antibiotics was determined by a serial dilution method in serum blood broth. When the in vitro sensitivity had been determined, penicillin was given in a dosage calculated to produce blood levels 4 to 5 times that required for in vitro inhibition. The blood levels of penicillin' resulting from various daily dosage of penicillin are listed in table 1.
The penicillin was administered by continuous intramuscular drip in most patients; in a few patients who were unable to tolerate a continuous drip, intermittent intramuscular injections were employed. Penicillin therapy was continued for 21 days, at which time it was discontinued and blood cultures obtained. If cured, the patients were discharged and followed in the cardiac clinic with From the University of Southern California, School of Medicine, Departments of Cardiology and Microbiology, and the Los Angeles County Hospital, Los Angeles, Calif. 668 periodic blood cultures. The management of those patients in whom positive cultures persisted after the initial course of therapy will be discussed later in the paper. 
STREPTOCOCCUS ENDOCARDITIS
Of the 64 patients in this report, 46 (72 per cent) were infected by a streptococcus, as proved by isolation of the organism from the blood stream. In the remaining 18 patients (28 per cent) a staphylococcus was found to be the cause of illness.
Cures and Mortality
Thirty-seven (80 per cent) of the patients with streptococcus endocarditis were cured, and 9 cases (20 per cent) had a fatal outcome during treatment. The cause of death in these patients was heart failure, cerebral embolus, myocardial infarction, uremia, and sepsis. In addition, 5 of the 37 cured patients died of congestive heart failure after completion of therapy. Circulation, Volume II, November, 1950 Penicillin Sensitive Streptococcus Endocarditis Cures. In table 2 are listed 24 patients in whom the infecting organisms were initially sensitive to penicillin in vitro, requiring 0.8 unit or less of penicillin per cc. of culture for in vitro inhibition.* In 21 or these patients, an alpha (table 3) . All 5 were sensitive to penicillin and responded to the initial course of penicillin. Death due to congestive failure occurred 1 to 12 months after completion of penicillin therapy.
Deaths During Treatment. Deaths before completion of penicillin therapy occurred in 5 patients in whom an alpha streptococcus endocarditis was present (table 4). The recovered organisms in this group were all sensitive to penicillin, requiring 0.02 to 0.09 unit per cc of culture for in vitro inhibition. Death in 2 of viridans streptococcus was isolated. The remaining 3 were caused by gamma streptococci. Penicillin therapy in a dosage varying from 0.4 to 8 million units daily for 21 days proved effective and these patients were all discharged as cured. All have been free from recurrence for 2 to 36 months after completion of therapy.
* Organisms requiring less than 1 unit of penicillin per cc. of culture for in vitro inhibition are considered relatively sensitive to penicillin, and those requiring 1 or more units are considered to be relatively resistant.
these resulted from multiple cerebral emboli; in the rest the cause of death was undetermined. Failure to Respond to Initial Course of Penicillin. The cause of therapeutic failure in occasional patients with penicillin sensitive bacterial endocarditis is not known. Case 35 (table 5) had a relatively sensitive organism, requiring 0.4 unit of penicillin per cc. for in vitro inhibition. Positive blood cultures persisted after two courses of 2.4 and 16 million units of penicillin daily for 21 days each. Finally 32 million units daily for 12 days effected a cure. Case 36 responded to 5 million units daily for 21 days after failure to respond to 1 million units daily for a similar period. For the third patient (case 37) the initial dosage of 320,000 units of penicillin daily was inadequate. Although the patient was cured by streptomycin, it is felt that a repeated course of penicillin in a dosage of 2 to 4 million units daily should have been the treatment of choice, because of potential toxic-determined and it was found that 2 to 4 gg. of aureomycin per cc. of culture produced in vitro inhibition of bacterial growth.
In 3 patients (cases 38, 39 and 42) 10 to 20 million units of penicillin daily for 21 days did not result in negative blood cultures. One of these patients (case 42) also received 4 Gm. of aureomycin daily. In all 3 patients, 20 million units of penicillin daily were administered for ity of prolonged treatment with streptomycin in large dosage.
Penicillin Resistant Streptococcus Endocarditis
There were 9 patients (20 per cent) in whom the organism was found to be relatively resistant to penicillin, requiring from 1.5 to 25 units of penicillin per cc. of culture for in vitro inhibition. Five of these were cured and 4 had a fatal outcome.
Cures. In table 6, bacterial sensitivity studies and therapeutic response have been correlated in 5 patients in whom penicillin resistant streptococci had been recovered. In all of these gamma streptococci with increased resistance to penicillin were recovered. In 3 patients (cases 38, 39 and 42) the gamma streptococci were resistant to from 125 to 250 Mg. or more of streptomycin per cc. of culture. In 2 patients (cases 41 and 42) aureomycin sensitivity was an additional 3 to 6 weeks and resulted in cures. Case 40 was initially treated with penicillin despite negative blood cultures. When positive cultures were obtained after the initial treatment, it was not known if this represented a relapse or reinfection. Penicillin was given therefore in a dosage of 20 million units daily for 42 days and effected a cure. Case 41 had a penicillin resistant gamma streptococcus endocarditis which was cured by 4 million units of penicillin daily for 2 days and 3 Gm. of aureomycin daily for 21 days. A reinfection with a penicillin resistant and aureomycin sensitive alpha streptococcus was cured by 20 million units of penicillin and 3 Gm. of aureomycin daily for 21 days.
Fatalities. There were 4 patients with streptococcus endocarditis in whom the organisms exhibited increased resistance to penicillin (table 7) . All of these died during penicillin therapy and the causes of death as listed were cerebral thrombosis and heart failure, myocardial infarction, sepsis and uremia. The dosage of penicillin employed in all of these was thought to have been inadequate and varied from 800,000 to 8 million units daily. One patient (case 45) was initially started on 4 million units daily and for 2 days prior to death received 20 million units daily. It may be significant that all the patients who were cured received 20 million units daily, in contrast to the therapy given the 4 fatal cases. However, in the patients dying of uremia, cerebral thrombosis and myocardial infarction it is impossible to say that increased dosage of penicillin initially would have altered the course. 
STAPHYLOCOCCUS ENDOCARDITIS
During the three year period, 1947 to 1949 inclusive, 18 patients with staphylococcus endocarditis were seen at the Los Angeles County Hospital. The endocarditis in 9 of these patients was caused by Staphylococcus aureus, and in 9 the causative organism was Staphylococcus albus. These patients are discussed separately from the streptococcus group because of sharp differences noted in mortality and resistance to antibiotics.
Mortality
Twelve, or 66 per cent, of these 18 cases had a fatal outcome. The fatalities were equally divided between S. aureus and S. albus, 6 patients dying in each group. The authors were impressed by the acute and fulminating course in the 6 fatal cases of S. aureus endocarditis. All of these patients were dead within three weeks after the onset of their illness (table 8) . At postmortem examination all had acute ulcerative and vegetative valvulitis. Five of the 6 had multiple septic infarcts and abcesses of the myocardium, liver, kidney, spleen, bone, and brain. The sixth patient died of a massive cerebral embolus. The patients with S. albus endocarditis had a much more prolonged and subacute course, the illness lasting from three weeks to as long as 10 months. This suggests that the strains of S. aureus in these patients were much more virulent than those of 8. albus. Other evidence supporting this thought is the fact that all of the recovered S. aureus organisms were coagulase positive, whereas all but one of the S. albus were coagulase negative.
Resistance to Antibiotics and Therapeutic Response Various reports of increasing resistance of staphylococci to penicillin have appeared in the literature.3-5 Barber3 in 1946 studied various strains of staphylococci and found that 14 per cent were penicillin resistant, requiring more than 10 units of penicillin per cc. of culture for in vitro inhibition. By June 1948, in the same hospital, the incidence of penicillin resistant staphylococci had increased to 59 per cent.
In Tables 9 and 10 bacterial sensitivity to antibiotics has been correlated with therapeutic response to antibiotics. Case 52 was seen at another hospital and has been included because of some interesting and valuable features that it presented.
Increased Resistance of S. Aureus to Penicillin. Of the 10 patients with S. aureus endocarditis (table 9), 4 were initially resistant to penicillin, and in a fifth patient (case 50) the organism was sensitive at first, being inhibited by 0.1 unit of penicillin per cc. of culture, but by the end of two weeks the resistance of the organism had increased so that 60 units of penicillin per cc. of culture were necessary for inhibition.
There were 2 patients (cases 48 and 49) who exhibited marked bacterial resistance to penicillin. The organism in both of these was sensitive to aureomycin, being inhibited by 1 gg. per cc. of culture. After massive dosage penicillin therapy failed to give a response, aureomycin in a dosage of 1 Gm. every six hours resulted in a prompt drop in the temperature to normal within 24 hours. Aureomycin was continued for 21 days and both patients were discharged as cured after numerous negative blood cultures. At the present time, both are well, 12 and 24 months respectively after discharge.
Increasing Resistance of S. Aureus to Aureomycin. A fatal case of S. aureus endocarditis venous aureomycin was given in a dosage of .3 to 1 Gm. every 6 hours. After nine days of therapy the temperature had returned to normal, but blood cultures at this time still contained S. aureus. Bacterial sensitivity studies showed that the resistance of the organism had increased so that 40 Mg. of aureomycin were now required for bacterial inhibition. Unfortunately aureomycin was not available for the 4 patients resistant to penicillin so that little can be said concerning the value of aureomycin in S. alburs endocarditis. Three patients with S. albus septicemia were seen on the pediatric wards during the past year, and all 3 were resistant to penicillin, requiring 180 units of penicillin per cc. of culture for in vitro inhibition. The organisms in these cases were all sensitive to aureomvyin, requiring 1 to 2 pg. for in vitro inhibition. Aureomycin therapy in these patients was very effective after penicillin had failed. This suggests that aureomycin may prove an effective antibiotic in penicillin resistant staphylococcus endocarditis. 1)IscussioN Streptococcus endocarditis, as seen at the Los Angeles County Hospital, differs from staphylococcus endocarditis in certain respects.
The mortality in 46 patients with streptococcus endocarditis was found to be 20 per cent, whereas in 18 patients with staphvlococcus endocarditis the mortality was 66 per cent. A contributing factor to the high mortality ill staphylococcus endocarditis patients is the fact that the patient infected with S. autreus had all acute and fulminating course with the rapi(d development of septic infarcts and abcesses ill the myocar(lium, kidney, spleen, brain, and other sites.
Bacterial Sensitivitiy Studies
Bacterial sensitivity studies showed that in 20 per cent of the patients With streptococcuis endocarditis the causative organism was resistant to penicillin, requiring from 1.5 to 25 units of penicillin for in vitro inhibition. In the group with staphylococcus endocarditis, in vitro bacterial sensitivity studies were done on 15 of 19 patients. In 66 per cent of the 15 patients studied the infecting organisms were resistant to penicillin and required from 1 to 200 units of penicillin per cc. of culture for inhibition. The degree of penicillin resistance in the patients with staphylococcus endocarditis was found to be greater than in patients with streptococcus endocarditis.
Therapeutic MlIan agement
Patients with penicillin sensitive streptococcus endocarditis responded, except for a few instances, to adequate dosage of penicillin given for 21 days. The patients with penicillin resistant streptococcus endocarditis who were cured required 20 million units of penicillin daily for periods varying from 21 to 42 days. After reviewing the histories of the patients in this series with penicillin resistant streptococcus endocarditis, it appears that such patients can be cured by 20 million units of penicillin daily for at least six weeks. At the present time little can be said about the value of aureomycin in penicillin resistant streptococcus endocarditis except that aureomycin sensitivity studies were done in 3 such patients and 2 to 4 jug. of aureomvcin resulted in in vitro inhibition. Two of the 3 patients (cases 41 and 42) received both penicillin and aureomycin for 21 days. One of them was cured by this method, but the other still had positive blood cultures at the end of treatment and was later cured by 20 million units of penicillin daily for 42 days. The aureomycin sensitivity tests done in these 3 patients suggest that this drug may be of value in penicillin resistant streptococcus endocarditis. Further investigation of the value of aureomycin in such patients is indicate(d.
In patients with penicillin resistant, staphylococcus endocarditis, aureomycin resulted in a cure in 2 patients (cases 48 and 49). In another patient (case 52) increasing resistance of a S. aureus to aureomvcin occurred during therapy so that by the tenth (lay of therapy 40 Mug. of aureomycin were required for in vitro inhibition.
(1) The response to therapy of 63 patients with lacterial endocarditis has been reported. Of this group 46 had streptococcus endocarditis and 19 staphylococcus endocarditis.
(2) In patients with streptococcus endocar-(litis, relative resistance to penicillin was found in 20 per cent, and in those with staphylococenrs endocarditis, in 66 per cent.
(3) In penicillin resistant streptococcus endocaiditis, 20 million units of penicillin daily for at least six weeks is recommended. Aureomycin sensitivity tests suggest that this drug may prove of value.
(4) In penicillin resistant staphylococcus en-(locarditis, aureomycin has been effective in 2 instances, and in a third patient increasing resistance to aureomn-cini developed during therapy.
